Skip to main content
Article thumbnail
Location of Repository

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria

By Julie Gutman, Michael Green, Salomon Durand, Ofelia Villalva Rojas, Babita Ganguly, Wilmer Marquiño Quezada, Gregory C Utz, Laurence Slutsker, Trenton K Ruebush and David J Bacon
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1998). Crevoisier C: Lack of bioequivalence of a generic mefloquine tablet with the standard product.
  2. (1994). Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine. Bull World Health Organ
  3. (2001). Organization: Antimalarial drug combination therapy: Report of WHO technical consultation. WHO/CDS/
  4. (2001). Organization: The use of antimalarial drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/
  5. Saraty S: [An efficacy and tolerance study of oral artesunate alone and in combination with mefloquine in the treatment of uncomplicated falciparum malaria in an
  6. (2003). TK II: Efficacy of mefloquine and a mefloquineartesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg
  7. (2006). Tobon A: Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malar J
  8. (2000). WH: Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria.
  9. (2007). White NJ: Artemisinin-based combination treatment of falciparum malaria.
  10. (1992). White NJ: Highdose mefloquine in the treatment of multidrug-resistant falciparum malaria.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.